BioCentury | Nov 2, 2009
Company News

British Canadian Biosciences, Oncolytics deal

...Oncolytics received an option from British Canadian Biosciences to acquire all rights to an undisclosed peptide to treat...
...to start Phase II testing for the indication next half. In exchange for the option, British Canadian Biosciences...
...to the announcement of the deal. Oncolytics will also receive a 10% stake in British Canadian Biosciences. British Canadian Biosciences Corp....
Items per page:
1 - 1 of 1
BioCentury | Nov 2, 2009
Company News

British Canadian Biosciences, Oncolytics deal

...Oncolytics received an option from British Canadian Biosciences to acquire all rights to an undisclosed peptide to treat...
...to start Phase II testing for the indication next half. In exchange for the option, British Canadian Biosciences...
...to the announcement of the deal. Oncolytics will also receive a 10% stake in British Canadian Biosciences. British Canadian Biosciences Corp....
Items per page:
1 - 1 of 1